Anik Patel, PhD

Anik is an internationally recognized expert in health economics, pharmaceutical policy, and global market access strategy. He brings more than a decade of biopharmaceutical experience overseeing therapeutic franchises from early-phase clinical development through launch and global regulatory approval.

His expertise includes value evidence strategy, payer engagement, and market access planning to support successful reimbursement and commercialization outcomes. He has led cross-functional initiatives aligning clinical development, health economics, and pricing strategy across international markets.

Anik advises on evidence generation and value communication to optimize regulatory and reimbursement success.